慢性骨髓性白血病:一个综述
Elias Jabbour1, Hagop Kantarjian1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.
JAMA
|March 17, 2025
概括
铁酶抑制剂显著改善了慢性髓性白血病 (CML) 患者的生存率,结果与一般人群相似. 仔细选择和遵守TCI对于有效管理CML至关重要.
科学领域:
- 血液学
- 癌症学
- 分子生物学
背景情况:
- 慢性骨髓性白血病 (CML) 是一种由费城染色体和BCR::ABL1瘤基因特征的骨髓增殖性瘤.
- 美国约有15万人患有慢性肺炎,全球约有500万人患有慢性肺炎,每年每10万人有2例患病.
- 患者通常处于慢性阶段 (90%),较为罕见的形阶段 (1-2%).
研究的目的:
- 审查使用氨酸激酶抑制剂 (TKI) 治疗CML的现状.
- 突出TKI对患者生存和治疗选择的影响.
- 强调药物坚持和管理副作用的重要性.
主要方法:
- 对CML发病,治疗和结局的当前文献的综述.
- 对TKI疗效,副作用和治疗指南的分析.
- 检查全源造血干细胞移植的作用.
主要成果:
- 自2000年以来,TKI已将与CML相关的死亡率从每年10-20%降至1-2%,实现了与年龄相匹配的人口相比的生存率.
- 美国食品和药物管理局批准了6种BCR::ABL1TKI,其中5种用于一线治疗,5种用于疾病进展.
- 第二代和第三代TKIs提供了更好的BCR::ABL1清除,但所有TKIs都有相关的毒性,需要仔细考虑.
结论:
- 这种疗法彻底改变了CML的治疗方法,
- 持续的TKI治疗往往是必要的,根据不良反应进行仔细的选择,并最大限度地提高患者的坚持.
- 异性干细胞移植仍然是耐火或不耐受患者的选择.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.9K
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.8K
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:27Disorders of Leukocytes
823
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
823